Merck & Co., Inc. and Eisai announce Phase 3 trial results for WELIREG plus LENVIMA in advanced renal cell carcinoma Read more
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData Read more
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines Read more